A novel function for vimentin: The potential biomarker for predicting melanoma hematogenous metastasis

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Li, Man ^b   Zhang, Baogang ^c   Wang, Xuan ^a   Ban, Xinchao ^a   Sun, Tao ^a   Liu, Zhiyong ^a   Zhao, Xiulan ^a   Sun, Baocun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c TIANJIN CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA ACTIN; ENOLASE; GAMMA ACTIN; GLUCOSE REGULATED PROTEIN 78; LAMININ BINDING PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALDIVES; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; ENZYME IMMUNOASSAY; EXPERIMENTAL MELANOMA; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SKIN TUMOR; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 77955394992     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-109     Document Type: Article

References (34)

1. Cancer Facts & Figures 2009. American Cancer Society, Atlanta: American Cancer Society 2009
2. Recent trends in cutaneous melanoma incidence among whites in the United States. A Jemal SS Devesa P Harlge, J Natl Cancer Inst 2001 93 678 683 10.1093/jnci/93.9.678 11333289 (Pubitemid 32492808)
3. The Impact of Genomics in Understanding Human Melanoma Progression and Metastasis. S Ren S Liu P Howell Jr, Cancer Control 2008 15 202 215 18596672
4. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. A Alban SO David L Bjorkesten, Proteomics 2003 3 36 44 10.1002/pmic.200390006 12548632
5. The relationship of embolie homogeneity, number, size and viability to the incidence of experimental metastasis. IJ Fidler, Eur J Cancer 1973 9 223 227 4787857
6. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. B Sun D Zhang S Zhang, Cancer Lett 2007 249 188 197 10.1016/j.canlet.2006.08.016 16997457
7. Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis. X Zhang Y Guo Y Song, Proteomics 2006 6 5260 5268 10.1002/pmic.200600006 16947120
8. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. B Ryu DS Kim AM DeLuca, PLoS One 2007 4 2 e594
9. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. AI Riker SA Enkemann O Fodstad, BMC Med Genomics 2008 28 1 13
10. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. S Nambiar A Mirmohammadsadegh R Doroudi, Arch Dermatol 2005 141 165 173 10.1001/archderm.141.2.165 15724012
11. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. S Varambally J Yu B Laxman DR Rhodes, Cancer Cell 2005 8 393 406 10.1016/j.ccr.2005.10.001 16286247
12. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. F Rondepierre B Bouchon J Papon, Biochim Biophys Acta 2009 1794 61 69 18952200
13. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines. M Al-Ghoul TB Brück JL Lauer-Fields, J Proteome Res 2008 7 4107 4018 10.1021/pr800174k 18698805
14. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. W Zuidervaart PJ Hensbergen MC Wong, Invest Ophthalmol Vis Sci 2006 47 786 793 10.1167/iovs.05-0314 16505008
15. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. R Tonge J Shaw B Middleton, Proteomics 2001 1 377 396 10.1002/1615-9861(200103)1:3<377::AID-PROT377>3. 0.CO;2-6 11680884
16. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. G Taraboletti D Belotti R Giavazzi, J Natl Cancer Inst 1993 85 235 240 10.1093/jnci/85.3.235 8423629
17. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. SR Elshaw K Sisley N Cross, Br J Ophthalmol 2001 85 732 738 10.1136/bjo.85.6.732 11371496
18. GRP78 induction in cancer: therapeutic and prognostic implications. AS Lee, Cancer Res 2007 67 3496 3499 10.1158/0008-5472.CAN-07-0325 17440054
19. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. R Lemaire SA Menguellet J Stauber, J Proteome Res 2007 6 4127 4134 10.1021/pr0702722 17939699
20. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis. M Takashima Y Kuramitsu Y Yokoyama, Proteomics 2005 5 1686 1692 10.1002/pmic.200401022 15800975
21. Proteome analysis of human lung squamous carcinoma. C Li Z Xiao Z Chen, Proteomics 2006 6 547 558 10.1002/pmic.200500256 16342241
22. PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer. D Zieker I Königsrainer F Traub, Cell Physiol Biochem 2008 21 429 436 10.1159/000129635 18453750
23. Melanoma prognostic factors found in the dermatopathology report. MJ Payette M Katz JM Grant-Kels, Clinics in Dermatology 2009 27 53 74 10.1016/j.clindermatol.2008.09.006 19095154
24. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. J Wei G Xu M Wu, Anticancer Res 2008 28 327 334 18383865
25. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. C Zhou AM Nitschke W Xiong, Breast Cancer Res 2008 10 105 10.1186/bcr2210 19087274
26. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. YR Chen HF Juan HC Huang, J Proteome Res 2006 5 2727 2742 10.1021/pr060212g 17022644
27. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. JW Wang SY Peng JT Li, Cancer Lett 2009 281 71 81 10.1016/j.canlet.2009.02.020 19299076
28. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. MJ Hendrix EA Seftor YW Chu, J Natl Cancer Inst 1992 84 165 74 10.1093/jnci/84.3.165 1371813
29. Relationship between the Organization and Synthesis of Vimentin and the Metastatic capability of B16 melanoma Cells. A Ben-Ze'ev A Raz, Cancer Res 1985 45 2632 2641 4039222 (Pubitemid 15024435)
30. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. M Gonzales B Weksler D Tsuruta, Mol Biol Cell 2001 12 85 100 11160825
31. Integrins: bidirectional, allosteric signaling machines. RO Hynes, Cell 2002 110 673 687 10.1016/S0092-8674(02)00971-6 12297042
32. New insights of epithelial-mesenchymal transition in cancer metastasis. Y Wu BP Zhou, Acta Biochim Biophys Sin (Shanghai) 2008 40 643 50 10.1111/j.1745-7270.2008.00443.x 18604456
33. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. SK Dissanayake M Wade CE Johnson, J Biol Chem 2007 282 17259 17234 10.1074/jbc.M700075200 17426020
34. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. SR Alonso L Tracey P Ortiz, Cancer Res 2007 67 3450 3460 10.1158/0008-5472.CAN-06-3481 17409456